Last update Nov. 10, 2022
A molecule that is synthesized by joining Methionine to Adenosine which is naturally widely present in human body. Without any clear scientific base it is used for liver disorders, depression and osteoarthritis (Sharma 2017). It is a product with low therapeutic effectiveness. (INSALUD 2001). It comes from the liver metabolization of methionine. Oral and parenteral administration.
Since the last update we have not found published data on its excretion in breastmilk.
Its very low oral bioavailability minimizes the passage into plasma of the infant from ingested breast milk, except in the premature and in the immediate neonatal period in which there may be greater intestinal permeability.
It is a product with few and not serious side effects, although at high doses they can cause psychiatric symptoms in vulnerable people. (Goren 2004)
Expert authors consider the use of this medication possible during breastfeeding. (LactMed, Hale)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM